SCHEMBL9611281

SCHEMBL9611281

CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1CCNC(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.57
POLB P06746 2/20 0.45
MAPT P10636 1/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KLK7 P49862 1/20 0.42
KLK5 Q9Y337 1/20 0.42
SYK P43405 1/20 0.42
HTT P42858 1/20 0.42
KEAP1 Q14145 2/20 0.42
NFE2L2 Q16236 2/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705981 1.00 ABCB1 (0.57) ABCB1POLBMAPTLMNASMN1; SMN2
SCHEMBL2707560 0.84 ABCB1 (0.60) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL9611279 0.84 ABCB1 (0.60) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL8265943 0.84 ABCB1 (0.61) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL9611284 0.83 ABCB1 (0.51) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL3977625 0.83 ABCB1 (0.51) ABCB1LMNASMN1; SMN2KLK7KEAP1
SCHEMBL2707632 0.83 ABCB1 (0.51) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL24392263 0.82 NAMPT (0.51) ABCB1MAPTLMNASMN1; SMN2KLK7
SCHEMBL8572173 0.82 POLB (0.53) ABCB1POLBMAPTSYKHTT
SCHEMBL12299747 0.80 ABCB1 (0.49) ABCB1MAPTLMNASMN1; SMN2KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415486-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS CORP. (US) 2013-04-09 US disclosed
US-8415486-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS CORP. (US) 2013-04-09 US disclosed
US-20120135990-A1 IAP INHIBITORS TETRALOGIC PHARMACEUTICALS CORP. (US) 2012-05-31 US disclosed
WO-2010138666-A1 IAP INHIBITORS TETRALOGIC PHARMACEUTICALS CORP. (US) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135990-A1 IAP INHIBITORS XIAP, IAPP, BIRC5 ABCB1 393/4885POLB 3851/4885MAPT 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.